HFZS
839725
ChemPartner PharmaTech
300149
SanFeng Intelligent Equipment Group
300276
Hangzhou Shenhao Technology
300853
AMSKY Technology
300521
CN Stock MarketDetailed Quotes
603990 Suzhou MedicalSystem Techology
- 12.76
- -1.32-9.38%
Market Closed Dec 9 15:00 CST
3.91BMarket Cap-11342P/E (TTM)
13.98High12.67Low727.71KlotVolume13.40Open14.08Pre Close955.67MTurnover23.76%Turnover RatioLossP/E (Static)306.28MShares15.7352wk High4.26P/B3.91BFloat Cap6.9352wk Low15.49Limit Up306.28MShs Float33.21Historical High12.67Limit Down9.30%Amplitude4.27Historical Low--Dividend TTM13.13Avg Price366.35KlotAsk--Div YieldTTM100Lot Size306.46KlotBid
Suzhou MedicalSystem Techology News
Would Suzhou MedicalSystem Technology (SHSE:603990) Be Better Off With Less Debt?
Suzhou medicalsystem technology (603990.SH): A special division has been established to continue advancing the research and development of drone low-altitude rescue.
Gelonghui November 14th | Suzhou medicalsystem techology (603990.SH) stated on the investor interaction platform that the company has established a special business unit to continue the research and development work of low-altitude drone rescue, continuously connecting with emergency centers and following up on demands, constantly improving and testing the products.
Suzhou Medicalsystem Technology (603990.SH): will deeply explore in AI Asia Vets services and medical care and health field, to create a new growth curve.
On November 14, Glonghui reported that Suzhou Medicalsystem Technology (603990.SH) announced on the investor interaction platform that it established Suzhou Youmai Robot Co., Ltd. on September 12, 2024. The main operational scope includes the research and development and sales of asia vets. The company will deeply explore AI smart services and the medical health care field to create a new growth curve.
Maddie Technology: Maddie Technology Third Quarter 2024 Report
Maddie Technology 2024 Third Quarter Report
Suzhou medicalsystem technology (603990.SH): Intends to sell 100% equity of two subsidiaries.
GLEE10 reported on October 30th that Suzhou Medicalsystem Technology (603990.SH) announced that the company plans to sell 100% equity of Mianyang Xinhaoyuan New Energy Technology Co., Ltd. held by Mianyang Anjian Investment Co., Ltd. in cash and to sell 100% equity of Mainsource Electrical Technology (Suzhou) Co., Ltd. held by Suzhou Xinnuo New Energy Technology Co., Ltd.
It is expected that relevant national authorities will establish a low-altitude economic regulatory bureau.
①The establishment decision has been approved, and the new bureau is currently in preparation; ② The low-altitude economy set up a dedicated bureau, which can better coordinate resources at all levels to promote industrial development.
Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Share Price Boosted 41% But Its Business Prospects Need A Lift Too
Increasing Losses Over Year Doesn't Faze Suzhou MedicalSystem Technology (SHSE:603990) Investors as Stock Rallies 18% This Past Week
Suzhou MedicalSystem Technology (603990.SH): gradually forming a comprehensive low-altitude rescue solution based on drone and eVTOL technology.
On August 16th, Gelunhui reported that Suzhou MedicalSystem Technology Co., Ltd. stated on its investor interactive platform that the company has been deeply cultivating the medical sector for nearly 20 years, and is a leader in the industry in the collaborative treatment of critical and severe diseases in hospitals and the field of assisted reproduction. By combining Huawei Cloud's leading technologies in cloud computing & big models, the company promotes the high-quality development of smart medical care and promotes the landing of AI applications in emergency medical care. Recently, the company has vigorously promoted the industry integration of medical informatization business and cooperated with industry companies in the fields of low-altitude economy, health and wellness robots and other fields. In terms of low-altitude economic emergency rescue, it has reached cooperation with Xi'an Jiaotong University Taicang Zhihui Port.
Suzhou Medicalsystem Technology (603990.SH): Vice President Wu Di accumulated a shareholding of 0.052 million shares of the company's stock.
On August 12th, Gelunhui reported that Suzhou Medicalsystem Technology (603990.SH) has received a notification letter from its Vice President Mr. Wu Di regarding the completion of the shareholding plan. Wu Di has accumulated 52,000 shares through centralized bidding from February 1st to August 12th, 2024, accounting for 0.0170% of the company's total equity, with a total accumulated investment of 503,480 yuan. Among them, from February 1st to July 31st, 2024, he accumulated 49,000 shares, with a total investment of 479.
Suzhou Mediston Medical Technology Co., Ltd. 2024 Interim Report
Summary of the semi-annual report of Suzhou Midesun Medical Technology Co., Ltd. in 2024.
Suzhou Medicalsystem Technology (603990.SH) plans to sell 100% equity of Xinhao New Energy Fund.
On August 9, Gelunhui reported that Suzhou MedicalSystem Technology Co., Ltd. (603990.SH) is planning a major asset restructuring, intending to sell 100% equity of Mianyang Xinhao New Energy Technology Co., Ltd. (hereinafter referred to as 'Xinhao New Energy') held by the company (hereinafter referred to as the 'target assets'). The target assets of this transaction are 100% equity of Xinhao New Energy, a wholly-owned subsidiary of the company. After preliminary studies and calculations, it is expected that this transaction will constitute a major asset restructuring as stipulated in the 'Management Measures for Major Asset Restructuring of Listed Companies'. The transaction is still in the planning stage, and the counterparty and transaction price have not been determined, and whether it constitutes a related party transaction is yet to be determined.
Suzhou Medicalsystem Techology (603990.SH): Repurchased 1.1764% of the shares, and the company completed the repurchase.
On August 2nd, 2024, Suzhou Medicalsystem Technology (603990.SH) announced that it had completed its buyback program, purchasing a total of 3.603 million shares, accounting for 1.1764% of the company's total share capital. The highest purchase price was 8.86 yuan per share, the lowest purchase price was 7.76 yuan per share, and the average purchase price was 8.32 yuan per share, with a total funds used of 29.9662 million yuan.
Suzhou Medicalsystem Technology (603990.SH): No plans to enter the energy storage industry in the short term.
Suzhou Medicalsystem Techology (603990.SH) stated on their investor platform on July 26 that the company has no plans to enter the energy storage industry in the short term.
Suzhou Medicalsystem Technology (603990.SH): No large-scale cooperation with KIMI for the time being.
On July 26, Gelunhui reported that Suzhou Medicalsystem Technology (603990.SH) stated on the investor interaction platform that the company currently has no large models cooperating with KIMI.
Suzhou Medicalsystem Technology (603990.SH) has released a low-altitude rescue overall solution for fully autonomous intelligent AED drones.
On July 26th, Gelunhui, Suzhou MedicalSystem Technology Co., Ltd. (603990.SH) stated on the investor interaction platform that the company has officially signed a contract and unveiled the first completely autonomous intelligent AED drone rescue solution for low-altitude rescue jointly built by the company and the Taihu Robotics Industrial Park of Northwestern Polytechnical University in the “low-altitude + medical” field. In the future, the company will continue to innovate in the low-altitude emergency rescue field, gradually forming a complete solution for unmanned aerial vehicle (UAV) rapid transportation of medical equipment (AED, etc.), emergency supplies, eVTOL air emergency transfer, among others, combining UAV and eVTOL technologies.
Suzhou Medicalsystem Technology (603990.SH): has cumulatively repurchased 1.1764% of the shares.
On July 11, Gelunhui reported that Suzhou Medicalsystem Technology (603990.SH) has cumulatively repurchased 3,603,000 shares through centralized bidding trading method as of July 10, 2024, which accounts for 1.1764% of the total share capital of the company. This is an increase of 0.4845% compared to the previously disclosed number. The highest transaction price was 8.86 yuan/share and the lowest price was 7.76 yuan/share. The total amount paid was RMB 29.9662 million (excluding transaction fees). The proportion of the transferred project equity decreased during the reporting period, and the net income attributable to shareholders of the listed company decreased by 38.57% year-on-year.
Suzhou Medicalsystem Technology's performance forecast for the first half of 2024.
